Drug intelligence / Profile preview

RV 2457C

Development stage
Phase 3
Lead developer
Heinrich-Heine-Universität Düsseldorf
Modality
Small Molecules
Administration
Topical
01

Overview

RV 2457C is a high-protection sunscreen milk developed for the prevention of photoinduced skin lesions in patients with chronic cutaneous lupus erythematosus (CCLE). It provides broad-spectrum photoprotection against both ultraviolet A (UVA) and ultraviolet B (UVB) radiation, which are known triggers for the induction and exacerbation of cutaneous lesions in lupus patients. The product was evaluated in a Phase 3 clinical trial (NCT00470912) led by Heinrich-Heine University, Duesseldorf, specifically targeting patients with a history of positive provocative phototesting. The study aimed to assess the efficacy of the sunscreen in preventing UV-induced exacerbations across various forms of the disease, including discoid lupus erythematosus (DLE), subacute cutaneous lupus erythematosus (SCLE), and lupus erythematosus tumidus (LET).

Brand names
RV 2547CRV2547CRV-2547C
Other names
RV 2457C Sunscreen MilkRV2457C Sunscreen MilkRV-2457C Sunscreen Milk

Beyond the preview

Go deeper on RV 2457C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RV 2457C.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call